103 related articles for article (PubMed ID: 10741694)
1. The RB2/p130 gene: the latest weapon in the war against lung cancer?
Claudio PP; Caputi M; Giordano A
Clin Cancer Res; 2000 Mar; 6(3):754-64. PubMed ID: 10741694
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer.
Claudio PP; Howard CM; Pacilio C; Cinti C; Romano G; Minimo C; Maraldi NM; Minna JD; Gelbert L; Leoncini L; Tosi GM; Hicheli P; Caputi M; Giordano GG; Giordano A
Cancer Res; 2000 Jan; 60(2):372-82. PubMed ID: 10667590
[TBL] [Abstract][Full Text] [Related]
3. pRB2/p130 target genes in non-small lung cancer cells identified by microarray analysis.
Russo G; Claudio PP; Fu Y; Stiegler P; Yu Z; Macaluso M; Giordano A
Oncogene; 2003 Oct; 22(44):6959-69. PubMed ID: 14534545
[TBL] [Abstract][Full Text] [Related]
4. Reduced transcription of the RB2/p130 gene in human lung cancer.
Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
[TBL] [Abstract][Full Text] [Related]
5. Loss of pRb2/p130 expression is associated with unfavorable clinical outcome in lung cancer.
Caputi M; Groeger AM; Esposito V; De Luca A; Masciullo V; Mancini A; Baldi F; Wolner E; Giordano A
Clin Cancer Res; 2002 Dec; 8(12):3850-6. PubMed ID: 12473599
[TBL] [Abstract][Full Text] [Related]
6. Tumor-specific exon 1 mutations could be the 'hit event' predisposing Rb2/p130 gene to epigenetic silencing in lung cancer.
Cinti C; Macaluso M; Giordano A
Oncogene; 2005 Sep; 24(38):5821-6. PubMed ID: 16044156
[TBL] [Abstract][Full Text] [Related]
7. The role of pRb2/p130 protein in diagnosing lung carcinoma on fine needle aspiration biopsies.
Minimo C; Bibbo M; Claudio PP; De Luca A; Giordano A
Pathol Res Pract; 1999; 195(2):67-70. PubMed ID: 10093823
[TBL] [Abstract][Full Text] [Related]
8. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
[TBL] [Abstract][Full Text] [Related]
9. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
[TBL] [Abstract][Full Text] [Related]
10. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
Macaluso M; Cinti C; Russo G; Russo A; Giordano A
Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
[TBL] [Abstract][Full Text] [Related]
11. Who is the boss in the retinoblastoma family? The point of view of Rb2/p130, the little brother.
Paggi MG; Giordano A
Cancer Res; 2001 Jun; 61(12):4651-4. PubMed ID: 11406530
[TBL] [Abstract][Full Text] [Related]
12. RB and RB2/p130 genes demonstrate both specific and overlapping functions during the early steps of in vitro neural differentiation of marrow stromal stem cells.
Jori FP; Melone MA; Napolitano MA; Cipollaro M; Cascino A; Giordano A; Galderisi U
Cell Death Differ; 2005 Jan; 12(1):65-77. PubMed ID: 15459751
[TBL] [Abstract][Full Text] [Related]
13. RB2/p130 gene-enhanced expression down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in vivo.
Claudio PP; Stiegler P; Howard CM; Bellan C; Minimo C; Tosi GM; Rak J; Kovatich A; De Fazio P; Micheli P; Caputi M; Leoncini L; Kerbel R; Giordano GG; Giordano A
Cancer Res; 2001 Jan; 61(2):462-8. PubMed ID: 11212232
[TBL] [Abstract][Full Text] [Related]
14. Missing expression of pRb2/p130 in human retinoblastomas is associated with reduced apoptosis and lesser differentiation.
Bellan C; De Falco G; Tosi GM; Lazzi S; Ferrari F; Morbini G; Bartolomei S; Toti P; Mangiavacchi P; Cevenini G; Trimarchi C; Cinti C; Giordano A; Leoncini L; Tosi P; Cottier H
Invest Ophthalmol Vis Sci; 2002 Dec; 43(12):3602-8. PubMed ID: 12454024
[TBL] [Abstract][Full Text] [Related]
15. pRb2/p130 gene overexpression induces astrocyte differentiation.
Galderisi U; Melone MA; Jori FP; Piegari E; Di Bernardo G; Cipollaro M; Cascino A; Peluso G; Claudio PP; Giordano A
Mol Cell Neurosci; 2001 Mar; 17(3):415-25. PubMed ID: 11273639
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy of lung cancer.
Daniel JC; Smythe WR
Semin Surg Oncol; 2003; 21(3):196-204. PubMed ID: 14508853
[TBL] [Abstract][Full Text] [Related]
17. Expression of cell cycle-regulated proteins pRB2/p130, p107, E2F4, p27, and pCNA in salivary gland tumors: prognostic and diagnostic implications.
Russo G; Zamparelli A; Howard CM; Minimo C; Bellan C; Carillo G; Califano L; Leoncini L; Giordano A; Claudio PP
Clin Cancer Res; 2005 May; 11(9):3265-73. PubMed ID: 15867222
[TBL] [Abstract][Full Text] [Related]
18. The retinoblastoma-related Rb2/p130 gene is an effector downstream of AP-2 during neural differentiation.
Paggi MG; Bonetto F; Severino A; Baldi A; Battista T; Bucci F; Felsani A; Lombardi D; Giordano A
Oncogene; 2001 May; 20(20):2570-8. PubMed ID: 11420667
[TBL] [Abstract][Full Text] [Related]
19. Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo.
Ito I; Ji L; Tanaka F; Saito Y; Gopalan B; Branch CD; Xu K; Atkinson EN; Bekele BN; Stephens LC; Minna JD; Roth JA; Ramesh R
Cancer Gene Ther; 2004 Nov; 11(11):733-9. PubMed ID: 15486560
[TBL] [Abstract][Full Text] [Related]
20. Current status of gene therapy for lung cancer and head and neck cancer.
Moon C; Oh Y; Roth JA
Clin Cancer Res; 2003 Nov; 9(14):5055-67. PubMed ID: 14613982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]